Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1988 Jan 2;296(6614):29–33. doi: 10.1136/bmj.296.6614.29

New Drugs: Respiratory and allergic disease—I

K Fan Chung, Peter J Barnes
PMCID: PMC2544684  PMID: 2892563

Full text

PDF
29

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arkinstall W. W., Atkins M. E., Harrison D., Stewart J. H. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics. Am Rev Respir Dis. 1987 Feb;135(2):316–321. doi: 10.1164/arrd.1987.135.2.316. [DOI] [PubMed] [Google Scholar]
  2. Ayres J., Fish D. R., Wheeler D. C., Wiggins J., Cochrane G. M., Skinner C. Subcutaneous terbutaline and control of brittle asthma or appreciable morning dipping. Br Med J (Clin Res Ed) 1984 Jun 9;288(6432):1715–1716. doi: 10.1136/bmj.288.6432.1715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barnes P. J. Asthma therapy: basic mechanisms. Eur J Respir Dis Suppl. 1986;144:217–265. [PubMed] [Google Scholar]
  4. Barnes P. J., Greening A. P., Neville L., Timmers J., Poole G. W. Single-dose slow-release aminophylline at night prevents nocturnal asthma. Lancet. 1982 Feb 6;1(8267):299–301. doi: 10.1016/s0140-6736(82)91566-5. [DOI] [PubMed] [Google Scholar]
  5. Barnes P. J. The changing face of asthma. Q J Med. 1987 May;63(241):359–365. [PubMed] [Google Scholar]
  6. Borgå O., Andersson K. E., Edholm L. E., Fagerström P. O., Lunell E., Persson C. G. Enprofylline kinetics in healthy subjects after single doses. Clin Pharmacol Ther. 1983 Dec;34(6):799–804. doi: 10.1038/clpt.1983.252. [DOI] [PubMed] [Google Scholar]
  7. Brandon M. L., Weiner M. Clinical investigation of terfenadine, a non-sedating antihistamine. Ann Allergy. 1980 Feb;44(2):71–75. [PubMed] [Google Scholar]
  8. Brostoff J., Lockhart J. D. Controlled trial of terfenadine and chlorpheniramine maleate in perennial rhinitis. Postgrad Med J. 1982 Jul;58(681):422–423. doi: 10.1136/pgmj.58.681.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Burney P. G. Asthma mortality in England and Wales: evidence for a further increase, 1974-84. Lancet. 1986 Aug 9;2(8502):323–326. doi: 10.1016/s0140-6736(86)90012-7. [DOI] [PubMed] [Google Scholar]
  10. Cayton R. M., Webber B., Paterson J. W., Clark T. J. A comparison of salbutamol given by pressure-packed aerosol or nebulization via IPPB in acute asthma. Br J Dis Chest. 1978 Jul;72(3):222–224. doi: 10.1016/0007-0971(78)90045-1. [DOI] [PubMed] [Google Scholar]
  11. Chan T. B., Shelton D. M., Eiser N. M. Effect of an oral H1-receptor antagonist, terfenadine, on antigen-induced asthma. Br J Dis Chest. 1986 Oct;80(4):375–384. doi: 10.1016/0007-0971(86)90091-4. [DOI] [PubMed] [Google Scholar]
  12. Christensson P., Arborelius M., Jr, Lilja B. Salbutamol inhalation in chronic asthma bronchiale: dose aerosol vs jet nebulizer. Chest. 1981 Apr;79(4):416–419. doi: 10.1378/chest.79.4.416. [DOI] [PubMed] [Google Scholar]
  13. Chung K. F., Dent G., McCusker M., Guinot P., Page C. P., Barnes P. J. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet. 1987 Jan 31;1(8527):248–251. doi: 10.1016/s0140-6736(87)90066-3. [DOI] [PubMed] [Google Scholar]
  14. Chung K. F. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax. 1986 Sep;41(9):657–662. doi: 10.1136/thx.41.9.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cushley M. J., Lewis R. A., Tattersfield A. E. Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax. 1983 Dec;38(12):908–913. doi: 10.1136/thx.38.12.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cuss F. M., Dixon C. M., Barnes P. J. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet. 1986 Jul 26;2(8500):189–192. doi: 10.1016/s0140-6736(86)92489-x. [DOI] [PubMed] [Google Scholar]
  17. Damon M., Chavis C., Crastes de Paulet A., Michel F. B., Godard P. Effect of nedocromil sodium on TXB2, LTB4 and LTD4 synthesis by alveolar macrophages from asthmatic patients. Eur J Respir Dis Suppl. 1986;147:206–209. [PubMed] [Google Scholar]
  18. Deshpande A., McKenzie S. A. Short course of steroids in home treatment of children with acute asthma. Br Med J (Clin Res Ed) 1986 Jul 19;293(6540):169–171. doi: 10.1136/bmj.293.6540.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dorward A. J., Roberts J. A., Thomson N. C. Effect of nedocromil sodium on histamine airway responsiveness in grass-pollen sensitive asthmatics during the pollen season. Clin Allergy. 1986 Jul;16(4):309–315. doi: 10.1111/j.1365-2222.1986.tb01962.x. [DOI] [PubMed] [Google Scholar]
  20. Eady R. P., Greenwood B., Jackson D. M., Orr T. S., Wells E. The effect of nedocromil sodium and sodium cromoglycate on antigen-induced bronchoconstriction in the Ascaris-sensitive monkey. Br J Pharmacol. 1985 Jun;85(2):323–325. doi: 10.1111/j.1476-5381.1985.tb08864.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fanta C. H., Rossing T. H., McFadden E. R., Jr Glucocorticoids in acute asthma. A critical controlled trial. Am J Med. 1983 May;74(5):845–851. doi: 10.1016/0002-9343(83)91076-8. [DOI] [PubMed] [Google Scholar]
  22. Fleming D. M., Crombie D. L. Prevalence of asthma and hay fever in England and Wales. Br Med J (Clin Res Ed) 1987 Jan 31;294(6567):279–283. doi: 10.1136/bmj.294.6567.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Flenley D. C. New drugs in respiratory disorders: I. Br Med J (Clin Res Ed) 1983 Mar 12;286(6368):871–875. doi: 10.1136/bmj.286.6368.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Flenley D. C. New drugs in respiratory disorders: II. Br Med J (Clin Res Ed) 1983 Mar 19;286(6369):955–959. doi: 10.1136/bmj.286.6369.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Girard J. P., Sommacal-Schopf D., Bigliardi P., Henauer S. A. Double-blind comparison of astemizole, terfenadine and placebo in hay fever with special regard to onset of action. J Int Med Res. 1985;13(2):102–108. doi: 10.1177/030006058501300205. [DOI] [PubMed] [Google Scholar]
  26. Greening A. P., Baillie E., Gribbin H. R., Pride N. B. Sustained release oral aminophylline in patients with airflow obstruction. Thorax. 1981 Apr;36(4):303–307. doi: 10.1136/thx.36.4.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Gunawardena K. A., Smith A. P., Shankleman J. A comparison of metered dose inhalers with nebulizers from the delivery of ipratropium bromide in domiciliary practice. Br J Dis Chest. 1986 Apr;80(2):170–178. doi: 10.1016/0007-0971(86)90038-0. [DOI] [PubMed] [Google Scholar]
  28. Hendeles L., Iafrate R. P., Weinberger M. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products. Clin Pharmacokinet. 1984 Mar-Apr;9(2):95–135. doi: 10.2165/00003088-198409020-00001. [DOI] [PubMed] [Google Scholar]
  29. Holgate S. T. Clinical evaluation of nedocromil sodium in asthma. Eur J Respir Dis Suppl. 1986;147:149–159. [PubMed] [Google Scholar]
  30. Howarth P. H., Holgate S. T. Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever. Thorax. 1984 Sep;39(9):668–672. doi: 10.1136/thx.39.9.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Johnston I. D., Ayesh R., Alton E., Essex E. G., Cochrane G. M., Hetzel M. R. The pharmacokinetics of uniphyllin in nocturnal asthma. Br J Dis Chest. 1986 Jul;80(3):235–241. doi: 10.1016/0007-0971(86)90058-6. [DOI] [PubMed] [Google Scholar]
  32. Joseph M., Capron A., Thorel T., Tonnel A. B. Nedocromil sodium inhibits IgE-dependent activation of rat macrophages and platelets as measured by schistosome killing, chemiluminescence and enzyme release. Eur J Respir Dis Suppl. 1986;147:220–222. [PubMed] [Google Scholar]
  33. Karpel J. P., Appel D., Breidbart D., Fusco M. J. A comparison of atropine sulfate and metaproterenol sulfate in the emergency treatment of asthma. Am Rev Respir Dis. 1986 May;133(5):727–729. doi: 10.1164/arrd.1986.133.5.727. [DOI] [PubMed] [Google Scholar]
  34. Keating G., Mitchell E. A., Jackson R., Beaglehole R., Rea H. Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. Br Med J (Clin Res Ed) 1984 Aug 11;289(6441):348–351. doi: 10.1136/bmj.289.6441.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kemp J. P., Buckley C. E., Gershwin M. E., Buchman E., Cascio F. L., Chretien J. H., Foster T. S., Gordon W. E., Jakle C., Klemawesch S. J. Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis. Ann Allergy. 1985 Jun;54(6):502–509. [PubMed] [Google Scholar]
  36. Koëter G. H., Postma D. S., Keyzer J. J., Meurs H. Effect of oral slow-release terbutaline on early morning dyspnoea. Eur J Clin Pharmacol. 1985;28(2):159–162. doi: 10.1007/BF00609685. [DOI] [PubMed] [Google Scholar]
  37. Kraan J., Koëter G. H., vd Mark T. W., Sluiter H. J., de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol. 1985 Oct;76(4):628–636. doi: 10.1016/0091-6749(85)90786-9. [DOI] [PubMed] [Google Scholar]
  38. Laduron P. M., Janssen P. F., Gommeren W., Leysen J. E. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole. Mol Pharmacol. 1982 Mar;21(2):294–300. [PubMed] [Google Scholar]
  39. Lal S., Malhotra S., Gribben D., Hodder D. An open assessment study of the acceptability, tolerability and safety of nedocromil sodium in long-term clinical use in patients with perennial asthma. Eur J Respir Dis Suppl. 1986;147:136–142. [PubMed] [Google Scholar]
  40. Leung K. B., Flint K. C., Brostoff J., Hudspith B. N., Johnson N. M., Pearce F. L. A comparison of nedocromil sodium and sodium cromoglycate on human lung mast cells obtained by bronchoalveolar lavage and by dispersion of lung fragments. Eur J Respir Dis Suppl. 1986;147:223–226. [PubMed] [Google Scholar]
  41. Littenberg B., Gluck E. H. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med. 1986 Jan 16;314(3):150–152. doi: 10.1056/NEJM198601163140304. [DOI] [PubMed] [Google Scholar]
  42. Lunell E., Borgå O., Larsson R. Pharmacokinetics of enprofylline in patients with impaired renal function after a single intravenous dose. Eur J Clin Pharmacol. 1984;26(1):87–93. doi: 10.1007/BF00546714. [DOI] [PubMed] [Google Scholar]
  43. Löfdahl C. G., Barnes P. J. Calcium channel blockade and asthma--the current position. Eur J Respir Dis. 1985 Oct;67(4):233–237. [PubMed] [Google Scholar]
  44. Morgan M. D., Singh B. V., Frame M. H., Williams S. J. Terbutaline aerosol given through pear spacer in acute severe asthma. Br Med J (Clin Res Ed) 1982 Sep 25;285(6345):849–850. doi: 10.1136/bmj.285.6345.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Mygind N. Topical steroid treatment for allergic rhinitis and allied conditions. Clin Otolaryngol Allied Sci. 1982 Oct;7(5):343–352. doi: 10.1111/j.1365-2273.1982.tb01918.x. [DOI] [PubMed] [Google Scholar]
  46. Neuenkirchen H., Wilkens J. H., Oellerich M., Sybrecht G. W. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline. Eur J Respir Dis. 1985 Mar;66(3):196–204. [PubMed] [Google Scholar]
  47. Newman S. P., Millar A. B., Lennard-Jones T. R., Morén F., Clarke S. W. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax. 1984 Dec;39(12):935–941. doi: 10.1136/thx.39.12.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. O'Reilly J. F., Buchanan D. R., Sudlow M. F. Pressurised aerosol with conical spacer is an effective alternative to nebuliser in chronic stable asthma. Br Med J (Clin Res Ed) 1983 May 14;286(6377):1548–1548. doi: 10.1136/bmj.286.6377.1548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Okerholm R. A., Weiner D. L., Hook R. H., Walker B. J., Leeson G. A., Biedenbach S. A., Cawein M. J., Dusebout T. D., Wright G. J., Myers M. Bioavailability of terfenadine in man. Biopharm Drug Dispos. 1981 Apr-Jun;2(2):185–190. doi: 10.1002/bdd.2510020211. [DOI] [PubMed] [Google Scholar]
  50. Pauwels R., Van Renterghem D., Van der Straeten M., Johannesson N., Persson C. G. The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol. 1985 Oct;76(4):583–590. doi: 10.1016/0091-6749(85)90779-1. [DOI] [PubMed] [Google Scholar]
  51. Pierce R. J., Payne C. R., Williams S. J., Denison D. M., Clark T. J. Comparison of intravenous and inhaled terbutaline in the treatment of asthma. Chest. 1981 May;79(5):506–511. doi: 10.1378/chest.79.5.506. [DOI] [PubMed] [Google Scholar]
  52. Rachelefsky G. S., Wo J., Adelson J., Mickey M. R., Spector S. L., Katz R. M., Siegel S. C., Rohr A. S. Behavior abnormalities and poor school performance due to oral theophylline use. Pediatrics. 1986 Dec;78(6):1133–1138. [PubMed] [Google Scholar]
  53. Rafferty P., Holgate S. T. Terfenadine (Seldane) is a potent and selective histamine H1 receptor antagonist in asthmatic airways. Am Rev Respir Dis. 1987 Jan;135(1):181–184. doi: 10.1164/arrd.1987.135.1.181. [DOI] [PubMed] [Google Scholar]
  54. Rea H. H., Scragg R., Jackson R., Beaglehole R., Fenwick J., Sutherland D. C. A case-control study of deaths from asthma. Thorax. 1986 Nov;41(11):833–839. doi: 10.1136/thx.41.11.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Richards D. M., Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1984 Jul;28(1):38–61. doi: 10.2165/00003495-198428010-00003. [DOI] [PubMed] [Google Scholar]
  56. Riley P. A., Mather M. E., Keogh R. W., Eady R. P. Activity of nedocromil sodium in mast-cell-dependent reactions in the rat. Int Arch Allergy Appl Immunol. 1987;82(1):108–110. doi: 10.1159/000234299. [DOI] [PubMed] [Google Scholar]
  57. Rivington R. N., Calcutt L., Child S., MacLeod J. P., Hodder R. V., Stewart J. H. Comparison of morning versus evening dosing with a new once-daily oral theophylline formulation. Am J Med. 1985 Dec 20;79(6A):67–72. doi: 10.1016/0002-9343(85)90092-0. [DOI] [PubMed] [Google Scholar]
  58. Robuschi M., Vaghi A., Simone P., Bianco S. Prevention of fog-induced bronchospasm by nedocromil sodium. Clin Allergy. 1987 Jan;17(1):69–74. doi: 10.1111/j.1365-2222.1987.tb02321.x. [DOI] [PubMed] [Google Scholar]
  59. Rossing T. H., Fanta C. H., Goldstein D. H., Snapper J. R., McFadden E. R., Jr Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis. 1980 Sep;122(3):365–371. doi: 10.1164/arrd.1980.122.3.365. [DOI] [PubMed] [Google Scholar]
  60. Scott P. H., Tabachnik E., MacLeod S., Correia J., Newth C., Levison H. Sustained-release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmacokinetics. J Pediatr. 1981 Sep;99(3):476–479. doi: 10.1016/s0022-3476(81)80354-x. [DOI] [PubMed] [Google Scholar]
  61. Sears M. R., Rea H. H., Fenwick J., Gillies A. J., Holst P. E., O'Donnell T. V., Rothwell R. P. 75 deaths in asthmatics prescribed home nebulisers. Br Med J (Clin Res Ed) 1987 Feb 21;294(6570):477–480. doi: 10.1136/bmj.294.6570.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Shapiro G. G., Furukawa C. T., Pierson W. E., Gardinier R., Bierman C. W. Double-blind evaluation of methylprednisolone versus placebo for acute asthma episodes. Pediatrics. 1983 Apr;71(4):510–514. [PubMed] [Google Scholar]
  63. Shaw R. J., Kay A. B. Nedocromil, a mucosal and connective tissue mast cell stabilizer, inhibits exercise-induced asthma. Br J Dis Chest. 1985 Oct;79(4):385–389. doi: 10.1016/0007-0971(85)90073-7. [DOI] [PubMed] [Google Scholar]
  64. Siegel D., Sheppard D., Gelb A., Weinberg P. F. Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma. Am Rev Respir Dis. 1985 Aug;132(2):283–286. doi: 10.1164/arrd.1985.132.2.283. [DOI] [PubMed] [Google Scholar]
  65. Sly R. M. Increases in deaths from asthma. Ann Allergy. 1984 Jul;53(1):20–25. [PubMed] [Google Scholar]
  66. Stewart C. J., Nunn A. J. Are asthma mortality rates changing? Br J Dis Chest. 1985 Jul;79(3):229–234. [PubMed] [Google Scholar]
  67. Stolley P. D., Schinnar R. Association between asthma mortality and isoproterenol aerosols: a review. Prev Med. 1978 Dec;7(4):519–538. doi: 10.1016/0091-7435(78)90265-7. [DOI] [PubMed] [Google Scholar]
  68. Toogood J. H., Baskerville J., Jennings B., Lefcoe N. M., Johansson S. A. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis. 1984 May;129(5):723–729. doi: 10.1164/arrd.1984.129.5.723. [DOI] [PubMed] [Google Scholar]
  69. Ward M. J., Macfarlane J. T., Davies D. A place for ipratropium bromide in the treatment of severe acute asthma. Br J Dis Chest. 1985 Oct;79(4):374–378. doi: 10.1016/0007-0971(85)90071-3. [DOI] [PubMed] [Google Scholar]
  70. Warren J. B., Cuss F., Barnes P. J. Posture and theophylline kinetics. Br J Clin Pharmacol. 1985 May;19(5):707–709. doi: 10.1111/j.1365-2125.1985.tb02701.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Weinberger M., Hendeles L. Current concepts. Slow-release theophylline rationale and basis for product selection. N Engl J Med. 1983 Mar 31;308(13):760–764. doi: 10.1056/NEJM198303313081306. [DOI] [PubMed] [Google Scholar]
  72. Wells E., Jackson C. G., Harper S. T., Mann J., Eady R. P. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. J Immunol. 1986 Dec 15;137(12):3941–3945. [PubMed] [Google Scholar]
  73. Wilson J. D., Sutherland D. C., Thomas A. C. Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma? Lancet. 1981 Jun 6;1(8232):1235–1237. doi: 10.1016/s0140-6736(81)92403-x. [DOI] [PubMed] [Google Scholar]
  74. Youngchaiyud P., Lee T. B. Effect of nedocromil sodium on the immediate response to antigen challenge in asthmatic patients. Clin Allergy. 1986 Mar;16(2):129–134. doi: 10.1111/j.1365-2222.1986.tb00756.x. [DOI] [PubMed] [Google Scholar]
  75. Zwillich C. W., Sutton F. D., Neff T. A., Cohn W. M., Matthay R. A., Weinberger M. M. Theophylline-induced seizures in adults. Correlation with serum concentrations. Ann Intern Med. 1975 Jun;82(6):784–787. doi: 10.7326/0003-4819-82-6-784. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES